Neon Therapeutics, Inc. (NTGN) News

Neon Therapeutics, Inc. (NTGN): $3.07

0.23 (+8.10%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add NTGN to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

NR

Ranked


in industry

Filter NTGN News Items

NTGN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest NTGN News From Around the Web

Below are the latest news stories about Neon Therapeutics Inc that investors may wish to consider to help them evaluate NTGN as an investment opportunity.

Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – HXL, AMTD, FSB, NTGN

NEW YORK, March 12, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders..

Yahoo | March 12, 2020

Lifshitz & Miller LLP Announces Investigation of Neon Therapeutics, Inc., Stein Mart, Inc., and Taubman Centers, Inc.

NEW YORK, March 11, 2020 -- Neon Therapeutics, Inc. (NASDAQ:NTGN) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with.

Yahoo | March 11, 2020

Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - FSB, NTGN, HXL

NEW YORK, NY / ACCESSWIRE / March 9, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ...

Yahoo | March 9, 2020

MEET, AMTD, NTGN, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

WILMINGTON, Del., March 09, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: The Meet Group, Inc. (NASDAQ GS: MEET) regarding possible breaches of.

Yahoo | March 9, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - HXL, NTGN, AMTD

NEW YORK, NY / ACCESSWIRE / March 4, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ...

Yahoo | March 4, 2020

Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Neon Therapeutics, Central Federal Bancshares, Franklin Financial Network, and Changyou.com Limited on behalf of Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Jan. 24, 2020 /PRNewswire/ -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Neon Therapeutics, Inc. (NASDAQ: NTGN), Central Federal Bancshares, Inc. (Other OTC: CFDB), Franklin Financial Network, Inc….

PR Newswire | January 24, 2020

Neon Therapeutics News: NTGN Stock Rockets 38% on BioNTech Deal

Neon Therapeutics (NTGN ) news for Thursday about a $67.00 million deal with BioNTech (BNTX) has NTGN stock soaring on Thursday.

InvestorPlace | January 16, 2020

The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 3) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS ) Ardelyx Inc (NASDAQ: ARDX )(announced positive results for the Phase 3 study of tenapanor as monotherapy for treating hyperphosphatemia in patients with chronic kidney disease on dialysis) Audentes Therapeutics Inc (NASDAQ: BOLD )( announced a deal to be bought by ASTELLAS PHARMA/ADR (OTC: ALPMY )) Axsome Therapeutics Inc (NASDAQ: AXSM )(announced positive mid-stage readout for drug to treat narcolepsy) Cassava Sciences Inc (NASDAQ: SAVA ) Constellation Pharmaceuticals Inc (NASDAQ: CNST ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) DexCom, Inc. (NASDAQ: DXCM ) ...

Benzinga | December 4, 2019

The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) (raised full-year guidance following completion of Otezla purchase from Celgene) Antares Pharma Inc (NASDAQ: ATRS ) Arvinas Inc (NASDAQ: ARVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) BIO-TECHNE Corp (NASDAQ: TECH ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Cue Biopharma Inc (NASDAQ: CUE ) Epizyme Inc (NASDAQ: EPZM ) Kamada Ltd. (NASDAQ: KMDA ) Kodiak Sciences Inc (NASDAQ: KOD ) Molecular Templates Inc (NASDAQ: MTEM ) Recro Pharma Inc (NASDAQ: REPH ) (completed spin-off of Baudax Bio in a bid to a b...

Benzinga | November 22, 2019

Neon Therapeutics (NASDAQ:NTGN) Downgraded to “Neutral” at Bank of America

Bank of America downgraded shares of Neon Therapeutics (NASDAQ:NTGN) from a buy rating to a neutral rating in a research note released on Wednesday morning, Briefing.com Automated Import reports. Other research analysts have also recently issued reports about the company. ValuEngine upgraded Neon Therapeutics from a hold rating to a buy rating in a research […]

Modern Readers | November 17, 2019


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!